Paracellular and transcellular migration of metastatic cells through the cerebral endothelium.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
04 2019
Historique:
received: 16 10 2018
revised: 14 11 2018
accepted: 27 12 2018
pubmed: 4 2 2019
medline: 16 7 2020
entrez: 4 2 2019
Statut: ppublish

Résumé

Breast cancer and melanoma are among the most frequent cancer types leading to brain metastases. Despite the unquestionable clinical significance, important aspects of the development of secondary tumours of the central nervous system are largely uncharacterized, including extravasation of metastatic cells through the blood-brain barrier. By using transmission electron microscopy, here we followed interactions of cancer cells and brain endothelial cells during the adhesion, intercalation/incorporation and transendothelial migration steps. We observed that brain endothelial cells were actively involved in the initial phases of the extravasation by extending filopodia-like membrane protrusions towards the tumour cells. Melanoma cells tended to intercalate between endothelial cells and to transmigrate by utilizing the paracellular route. On the other hand, breast cancer cells were frequently incorporated into the endothelium and were able to migrate through the transcellular way from the apical to the basolateral side of brain endothelial cells. When co-culturing melanoma cells with cerebral endothelial cells, we observed N-cadherin enrichment at melanoma-melanoma and melanoma-endothelial cell borders. However, for breast cancer cells N-cadherin proved to be dispensable for the transendothelial migration both in vitro and in vivo. Our results indicate that breast cancer cells are more effective in the transcellular type of migration than melanoma cells.

Identifiants

pubmed: 30712288
doi: 10.1111/jcmm.14156
pmc: PMC6433661
doi:

Substances chimiques

Cadherins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2619-2631

Informations de copyright

© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Références

Mol Biol Cell. 2006 Mar;17(3):1261-72
pubmed: 16371504
Pigment Cell Melanoma Res. 2016 Nov;29(6):627-642
pubmed: 27615400
PLoS One. 2011;6(6):e20758
pubmed: 21674054
Eur J Immunol. 2015 Apr;45(4):1043-58
pubmed: 25545837
Ann Oncol. 2018 Jul 1;29(7):1509-1520
pubmed: 29790899
J Neurooncol. 2016 May;127(3):407-14
pubmed: 26909695
J Mol Recognit. 2017 Jun;30(6):
pubmed: 28008676
Traffic. 2017 Nov;18(11):733-746
pubmed: 28799243
Neuro Oncol. 2017 Jan;19(1):i1-i24
pubmed: 28031389
PLoS One. 2015 Mar 30;10(3):e0123845
pubmed: 25822751
J Cell Mol Med. 2012 Aug;16(8):1731-8
pubmed: 21883894
J Cell Mol Med. 2019 Apr;23(4):2619-2631
pubmed: 30712288
Acta Neurobiol Exp (Wars). 2011;71(1):113-28
pubmed: 21499332
J Cell Sci. 2009 Sep 1;122(Pt 17):3025-35
pubmed: 19692589
Cell Adh Migr. 2016 May 3;10(3):269-81
pubmed: 26645485
J Cereb Blood Flow Metab. 2018 Apr;38(4):563-587
pubmed: 28920514
Mol Ther. 2011 Feb;19(2):318-25
pubmed: 21045812
PLoS One. 2014 Feb 24;9(2):e89758
pubmed: 24587014
Neoplasia. 2018 Apr;20(4):387-400
pubmed: 29539586
Front Surg. 2016 May 25;3:30
pubmed: 27252942
Mol Biol Cell. 2005 Sep;16(9):4386-97
pubmed: 15987741
Cancer. 2018 Jan 15;124(2):297-305
pubmed: 29023643
Cancer Metastasis Rev. 1999;18(3):387-400
pubmed: 10721492
JAMA Oncol. 2017 Aug 1;3(8):1069-1077
pubmed: 28301662
PLoS One. 2014 Oct 02;9(10):e109748
pubmed: 25275457
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
Expert Opin Pharmacother. 2014 Aug;15(12):1643-58
pubmed: 25032884
Chem Soc Rev. 2012 Apr 7;41(7):2718-39
pubmed: 22389111
Acta Neuropathol. 2005 Feb;109(2):181-90
pubmed: 15549331
J Cell Sci. 2010 Feb 1;123(Pt 3):431-40
pubmed: 20067998
Front Neurosci. 2014 Dec 03;8:392
pubmed: 25520612
Cancer Control. 2009 Jul;16(3):248-55
pubmed: 19556965
Nat Commun. 2015 Apr 01;6:6716
pubmed: 25828099
Int J Mol Sci. 2013 Jan 11;14(1):1383-411
pubmed: 23344048

Auteurs

Hildegard Herman (H)

Institute of Life Sciences, Vasile Goldiş Western University of Arad, Arad, Romania.

Csilla Fazakas (C)

Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

János Haskó (J)

Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

Kinga Molnár (K)

Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Theoretical Medicine Doctoral School, University of Szeged, Szeged, Hungary.

Ádám Mészáros (Á)

Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Doctoral School of Biology, University of Szeged, Szeged, Hungary.

Ádám Nyúl-Tóth (Á)

Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

Gábor Szabó (G)

Medical Gene Technology Unit, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.

Ferenc Erdélyi (F)

Medical Gene Technology Unit, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.

Aurel Ardelean (A)

Institute of Life Sciences, Vasile Goldiş Western University of Arad, Arad, Romania.

Anca Hermenean (A)

Institute of Life Sciences, Vasile Goldiş Western University of Arad, Arad, Romania.

István A Krizbai (IA)

Institute of Life Sciences, Vasile Goldiş Western University of Arad, Arad, Romania.
Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

Imola Wilhelm (I)

Institute of Life Sciences, Vasile Goldiş Western University of Arad, Arad, Romania.
Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH